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TO THE EDITOR
Alopecia areata (AA) is characterized by
patchy, nonscarring, autoimmune-medi-
ated hair loss, although many aspects of
AA pathogenesis are unknown (Gilhar
et al., 2012). The scalp is most comm-
only involved in clinically treated AA,
but any hair-bearing surface of the body
may be affected (Wasserman et al.,
2007). Males and females of any age
and hair color can have AA (Finner,
2011; Kyriakis et al., 2009). According
to the first National Health and
Nutrition Examination Survey conduc-
ted in the early 1970s, AA is fairly
common; it was estimated to affect
about 2 of every 1,000 people in the
United States (Safavi, 1992). Dermato-
logists encounter AA in 0.7–4.0% of
their patient populations (Price, 1991;
Sharma et al., 1996; Tan et al., 2002). A
previous study reported by Mayo Clinic
and National Institutes of Health (Safavi
et al., 1995) showed that the overall
incidence of AA in Olmsted County,
Minnesota, was 20.2 per 100,000 per-
son-years from 1975 to 1989. A similar
incidence rate for both sexes with a
lifetime risk of 1.7% was observed.
The purpose of the current study was
to continue the previous analysis and
document the most current lifetime inci-
dence risk of AA. Clinical data accessed
via the Rochester Epidemiology Project
(REP) provided a retrospective review of
all patients resident in Olmsted County,
Minnesota, that were newly diagnosed
with AA from 1990 to 2009. Of 530
qualifying patients, the mean age at
diagnosis was 33.6 years (median, 33
years; range, 0–90 years). Additional
features for the study cohort are sum-
marized in Table 1. The mean age at
diagnosis of AA for males was 31.5 years
(median, 31 years; range, 0.5–80 years);
for females, it was 36.2 years (median,
36.4 years; range, 1.8–90.7 years).
As shown in Table 2, the age- and sex-
adjusted incidence of AA was 20.9 per
100,000 person-years (95% confidence
interval (CI), 19.1–22.6). Cumulative AA
incidence increased almost linearly with
age (0.3%, 20 years; 0.6%, 30 years;
0.8%, 40 years; 1.1%, 50 years; 1.4%,
60 years), while cumulative lifetime inci-
dence was 2.1%. Age-adjusted incidence
was 21.3 per 100,000 person-years
(95% CI, 18.8–23.9) for females and
20.2 per 100,000 person-years (95% CI,
17.7–22.6) for males (no significant
difference, P¼0.77), supporting the
observation that both females and males
display similar susceptibility to AA.
At 2.1%, the cumulative lifetime inci-
dence of AA from this recent 20-year
period (1990–2009) was slightly higher
than 1.7% observed in the older study
(years 1975–1989) (Safavi et al., 1995).
Similarly, REP data analyzed in
studies of other autoimmune-associated
diseases have shown that incidence of
rheumatoid arthritis (Myasoedova et al.,
2010) and systemic lupus erythe-
matosis (Uramoto et al., 1999) have
also increased in the region in recent
years. These data do not refute the
hypothesis that autoimmune disease
incidence may be rising, generally.
The current study also confirms that
AA does not exhibit a gender bias (Muller
and Winkelmann, 1963). Although some
studies have reported AA to be slightly
more common in females (Tan et al.,
2002; Goh et al., 2006; Kyriakis et al.,
2009), such findings might be attributable
to a greater cultural awareness of and
sensitivity to hair loss among females that
prompts them to seek medical attention.
Interestingly, in Turkey, a higher male:
female ratio (1.6:1) was reported for
patients with AA (Kavak et al., 2008).
The authors explained the likely artifi-
cial skew toward male patients in the
context of religious practices and sugge-
sted that the headscarves worn by
women may have allowed some to
avoid seeking medical attention for hair
loss. The predominantly white patient
population in the current study is reflec-
tive of the geographic race distribution
and is not a sign of racial differences in
AA prevalence. In conclusion, we asse-
ssed the incidence of AA in Olmsted
County, Minnesota, during a recent
20-year period (1990–2009), and found
that the lifetime incidence risk was 2.1%.
This study was approved by the insti-
tutional review boards of Mayo Clinic
and Olmsted Medical Center. The REP
medical records system links informa-
tion from all health care providers in
Olmsted County, Minnesota. It includes
medical records for all residents of the
county, regardless of where care was
received in the county. The relative
geographic isolation of Olmsted County
residents from other medical institu-
tions provides a unique opportunity
to conduct population-based analyses
(St Sauver et al., 2012).
The REP databank was used to identify
Olmsted County residents with their first
lifetime diagnosis of AA established from
1990 to 2009. Medical records of identi-
fied patients were reviewed and data
were abstracted. Each diagnosis was
validated by a physician and documen-
ted in the medical record.
Incidence rates per 100,000 person-
years were calculated using incident
cases of AA as the numerator and age-
and sex-specific estimates of the county
population as the denominator. The
populations at risk for the years 1990–
2000 were estimated using census data
from 1990 to 2000, with linear
interpolation for intercensal years. The
populations at risk for the years 2001–
2009 were obtained from US IntercensalAccepted article preview 11 November 2013; published online 5 December 2013
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Estimates (United States Census Bureau).
Because the population of Olmsted
County is nearly all white, incidence rates
were directly age- and sex-adjusted to the
structure of the 2000 US white popu-
lation. Incident cases were grouped on
the basis of age at diagnosis (0–9, 10–19,
20–29, 30–39, 40–49, 50–59, and X60
years) and year of diagnosis (1990–1994,
1995–1999, 2000–2004, and 2005–
2009). The relationships of age at diag-
nosis, sex, and year of diagnosis with
the incidence of AA were assessed by
fitting Poisson regression models using
the SAS procedure GENMOD (SAS Insti-
tute). P-values less than 0.05 were con-
sidered statistically significant.
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Table 1. Patient characteristics (n¼ 530)
Characteristic Number of patients (%)
Year of diagnosis (n¼ 530)
1990–1994 90 (17)
1995–1999 120 (23)
2000–2004 149 (28)
2005–2009 171 (32)
Female sex 271 (51)
Diagnosis
Dermatologist 460 (87)
Nondermatologist physician 70 (13)
Biopsy confirmation1 73 (14)
Race (n¼ 482)
White 423 (88)
Asian 30 (6)
Black 18 (4)
Hispanic or Latino 11 (2)
1All biopsy results were confirmed by dermatologists.
Table 2. Incidence of alopecia areata in Olmsted County, Minnesota,
1990–2009, stratified by age and sex
Females Males Total
Age at diagnosis No. of patients Rate1 No. of patients Rate1 No. of patients Rate1
0–9 27 14.9 32 16.7 59 15.8
10–19 33 19.4 26 14.6 59 17.0
20–29 49 27.1 58 32.9 107 29.9
30–39 45 23.1 73 37.2 118 30.1
40–49 52 27.1 36 19.2 88 23.2
50–59 35 25.4 24 18.1 59 21.8
X60 30 14.3 10 6.4 40 10.9
Total 271 21.32 259 20.22 530 20.93
1Incidence rates per 100,000 person-years.
2Incidence rates per 100,000 person-years were age-adjusted to the 2000 US white population.
3Incidence rates per 100,000 person-years were age- and sex-adjusted to the 2000 US white population.
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